Abstract
Background: Among the autoimmune diseases causing erosive lesions and blisters on skin and mucous membranes is pemphigus. Within this is a rare subtype known as seborrheic pemphigus or Senar-usher syndrome which is characterized by broken blisters and crusts involving the seborrheic areas. Its pathogenesis is related to an autoimmune mechanism leading to lysis of desmosomes; IgG antibodies against desmoglein 1 and 3, however, this may be a misguided theory.
Case report: A 40-year-old female patient recently diagnosed with HIV with no known time of evolution; she presented a condition of 45 days evolution consisting of pruritic and painful thick crusty lesions with erythematous base, in the entire facial region with subsequent extension to the chest, upper limbs and abdomen and finally to the genitals and lower limbs. She received oral prednisolone therapy with adequate improvement of the lesions.
Conclusion: It is a rare disease that can originate from states of immunosuppression secondary to pathologies such as HIV, so the current pathogenesis of pemphigus should be reconsidered.
References
Errichetti E, Stinco G, Pegolo E, Di Meo N, Trevisan G, Patrone P, "Seborrheic Pemphigoid", Cas Rep Dermatol Med, 2014, Article ID 768217, (4), 2014. https://doi.org/10.1155/2014/768217.
Carvajal EM, Jiménez TI, Francesa BG. Pénfigo Vulgar y Foliáceo: Una revisión bibliográfica. Rev Clin Esc Med 2019;9(1):48-55. http://dx.doi.org/10.15517/rc_ucr-hsjd.v9i1.36493.
Chokoeva AA, Lozev I, Yungareva I, Wollina U, Lotti T, Maximov GK, et al. Seborrheic Pemphigus, antigen mimicry and the subsequent-wrong diagnostic and therapeutic approach? Maced J Med Sci 2018; 6 (1):128–31. https://doi.org/10.3889/oamjms.2018.011.
Castro-Forés LLO, Cruz JML, Jamora MJJ, Canlas-Estrella KM. Seborrheic pemphigoid. JAAD Case Rep [Internet]. 2016;2(1):80–3. http://dx.doi.org/10.1016/j.jdcr.2015.12.010.
Fernández-Rueda P, Guevara-Cervantes JF, López LA, SalazaR E, et al. Penfigo seborreico. Dermatol Rev Méx 2015;59:303-309.
Bosch-Amate X, Iranzo P, Ivars M, Mascaró Galy JM, España A. Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases. Front Immunol. 2021 Sep 10;12:740820. doi: 10.3389/fimmu.2021.740820.
Eichkorn RA, Schmidt MF, Walter E, Hertl M, Baron JM, Waschke J, Yazdi AS. Innate immune activation as cofactor in pemphigus disease manifestation. Front Immunol. 2022 Jul 19;13:898819. doi: 10.3389/fimmu.2022.898819.
Murrell D, Werth V. Diagnosis and management of pemphigus: Recommendations of an international panel of experts. Journal of the American Academy of Dermatology 2020;82(3):575-585.e1. https://doi.org/10.1016/j.jaad.2018.02.021.
Touzeau-Roemer V, Skoll M, Tajpara P, Kienzl P, Wesinger A, Saluzzo S, et al. Prevalence of skin-specific autoantibodies in HIV-infected patients and uninfected controls. Acta Derm Venereol 2019;99(11):978–83. doi: 10.2340/00015555-3251.
Min MS, Damstetter E, Chen AYY. Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol 2018;4(3):159–65. https://doi.org/10.1016/j.ijwd.2018.02.002.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Revista Alergia México